Honoured to have been appointed Secretary General-Elect of the E-AHPBA at the recent congress in Dublin! I will do my very best to try to assist our association in becoming even more prosperous in the future.

Kinda neat technique...never seems to be a good way to manage these patients so good to have another approach in the tool box!

Leading voices in esophageal cancer come together across borders at the #ISDE2025 Congress. Explore how multidisciplinary thinking is shaping the future of upper GI oncology and inspiring new approaches to patient care. #ISDE5 #EsophagealDisease #oesophagus #esophagus

📢🔵Bemarituzumab press release Phase 3 FORTITUDE-101 ➡️FGFR2b overexpressed gastric cancer ➡️First-line bemarituzumab plus chemotherapy (mFOLFOX6) vs chemo ✅ OS benefit at a pre-specified interim analysis 🚨Most common TEAE (>25%): reduced visual acuity, punctate keratitis,

SANO trial: innovations, risks, and unanswered questions - felt very strongly along with several UGI colleagues we must highlight the important limitations of the SANO trial and thus counsel our patients appropriately regarding these results! ⁦ thelancet.com/journals/lanon…

Please to share our latest Mechanism of Cancer Drug Resistance paper! We demonstrate that AKT/mTOR is a key targetable hub for multi-modal therapy resistance in EGFR amplified or over expressed Oesophageal Squamous Cell Carcinoma. (1/6) nature.com/articles/s4141…

Combining AKT/mTOR inhibitors with EGFR inhibitors in EGFR-driven ESCC shows synergism but with elevated toxicity. Combined therapy at reduced doses could offer improved, cost-effective therapy options for gefitinib-resistant cancer.(5/6)

A heartfelt thank you to our esteemed Gold Sponsor - Proteomics International - for their generous support and their commitment to advancing research and innovation in #esophageal health. Learn more at proteomics.com.au #ISDE2025 #Proteomics #EsophagealHealth #esophagus

The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review ➡️doi.org/10.1093/bjsope… Despite the heterogeneity of targets and in the absence of a commonly accepted definition, conversion

What is "Conversion surgery" 🐛➡️🦋 for upfront unresectable upper GI and HPB cancers ⁉️ 💉 Triggered by improvements in non surgical therapies 🧰 Many techniques included 🏆 Able to improve survival! 💡 All u need to know in ⬇ comprehensive review academic.oup.com/bjsopen/articl…

🚨Our latest study in Zenker’s Treatment Diseases of the Esophagus Journal 🚀 ✅2.14 better clinical success vs traditional methods (OR: 2.14) 👉97.4% technical success, fewer AEs 🏁Z-POEM shines as being safe and effective in elderly patients 🔗pubmed.ncbi.nlm.nih.gov/40654274/ 💡#ZPOEM #Thirdspace

🌆 Don’t miss the #ISDE2025 Congress Dinner on Sept 19! Dine above #Brisbane at the Sky Room with iconic views, Aussie flavors, live entertainment & great company. 📍 BCEC 🕖 7–10PM 👔 Biz casual 💵 $165 USD Secure your spot now👉isde-congress.net/registration/ #esophagus #esophageal

Coming to the ISDE.net meeting this September in Brisbane? Don’t miss the congress dinner!

From first signs to personalized therapies: Explore the full journey of EoE with global thought leaders. This session delivers an eye-opening exploration of one of today’s most talked-about #esophageal conditions. Check #ISDE2025 Program 👉isde-congress.net/2025-scientifi… #esophagus

That feeling when 7+ years of work lands on the front page of NEJM—and one of the people I respect most, Kohei shitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn Memorial Sloan Kettering Cancer Center

👀👀👀 Fantastic work and an extremely valuable research resource 👏👏👏

In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in high-grade adverse events. Full MATTERHORN phase 3 trial results and Research

So excited to see this paper on the stromal changes driving Barrett’s Esophagus progression to Cancer. A Herculean effort effort integrating scRNASeq/CODEX/ECM proteomics. Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics... sciencedirect.com/science/articl…

An Evening to Remember at #ISDE2025 Join us on Sep 19 for the Congress Dinner at the Sky Room & Terrace at BCEC 🥂 Mix, mingle, indulge in a buffet of Aussie favorites & enjoy live entertainment! Learn more👉isde-congress.net/social-program/ #Esophagus #Esophageal #Oesophagus #ISDE

Very pleased to share this review on FGFR2b which is a key emerging biomarker in gastric and gastroesophageal #Cancer Looking forward to seeing those FORTITUDE 101 results soon 👀! Hopefully #ESMO25 in Berlin! Thanks 🙏 to all my co-authors! sciencedirect.com/science/articl…